Clinical trial
Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of…
NCT00004851 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00004851 |
|---|---|
| Title | Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies |
| Official title | Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Hepatitis C |
| Enrollment | 1 |
| Start date | Apr 1, 1999 |
| Completion | May 1, 2001 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: